Market Overview - The Elastography Imaging Market was valued at USD 3.27 billion in 2024 and is projected to reach USD 5.88 billion by 2032, growing at a CAGR of 7.66% from 2025 to 2032 [1][8]. Growth Drivers - Increasing demand for non-invasive diagnostic procedures, especially for liver fibrosis, oncology, and musculoskeletal disorders, is significantly contributing to market growth [2]. - The U.S. Elastography Imaging Market was valued at USD 1.04 billion in 2024 and is projected to reach USD 1.84 billion by 2032, with a CAGR of 7.47% from 2025 to 2032, driven by strong healthcare infrastructure and high adoption of advanced imaging technologies [4]. Market Segmentation By Modality - Ultrasound holds a dominant market share of 70.52% in 2024, being cheaper and more portable than other imaging tools. MRI is the fastest-growing segment with a CAGR of 8.03% due to its high diagnostic accuracy [9]. By Application - The General Imaging segment dominated the market with a share of 34.80% in 2024, with breast elastography expected to witness the fastest growth during the forecast period [10]. By End-User - Hospitals represent the largest and fastest-growing segment, holding 41.30% of the market share and a CAGR of 8.05% due to established facilities and large patient quotas [11]. Regional Insights - North America accounted for 38.52% of the overall revenue share in 2024, primarily due to a developed healthcare system and high prevalence of chronic diseases [14]. - The Asia Pacific region is projected to grow at the fastest CAGR of 8.10% during the forecast period, driven by a large patient population and high prevalence of chronic diseases [15]. Recent Developments - In early 2024, Resoundant expanded MR Elastography clinical collaborations with academic hospitals in the U.S. and Europe [19]. - In March 2025, Siemens announced enhanced AI-assisted elastography analysis integrated into its ACUSON Sequoia system, improving real-time liver fibrosis staging [19].